Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Savolitinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Savolitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Selpercatinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Selpercatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Selumetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Selumetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Semaxanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Semaxanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Senaparib	PARP Inhibitor	Solid Tumour
Molecule Senaparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
SHR6390 (Dalpiciclib)	CDK Inhibitor	Solid Tumour
Molecule SHR6390 (Dalpiciclib) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Simmiparib	PARP Inhibitor	Solid Tumour
Molecule Simmiparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sitravatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Sitravatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sorafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Sorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sotorasib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Sotorasib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Stenoparib	PARP Inhibitor	Solid Tumour
Molecule Stenoparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sunitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Sunitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

Savolitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Selpercatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Selumetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Semaxanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Senaparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
SHR6390 (Dalpiciclib) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Simmiparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sitravatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Sotorasib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Stenoparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Sunitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

‹ 1 … 8 9 10 11 12 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Savolitinib

Selpercatinib

Selumetinib

Semaxanib

Senaparib

SHR6390 (Dalpiciclib)

Simmiparib

Sitravatinib

Sorafenib

Sotorasib

Stenoparib

Sunitinib

Savolitinib

Selpercatinib

Selumetinib

Semaxanib

Senaparib

SHR6390 (Dalpiciclib)

Simmiparib

Sitravatinib

Sorafenib

Sotorasib

Stenoparib

Sunitinib